Several pre-clinical research pointed out that GLP-1 RAs can ameliorate renal injury induced by aging and diabetes by reducing renal inflammation, relieving renal oxidative stress, and inhibiting renal fibrosis [12, 13, 147]. Here, GLP1R is linked to diabetes mellitus.